HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,200,296 | -50.5% | 96,813 | -56.0% | 0.03% | -48.4% |
| Q2 2023 | $22,646,542 | +296.7% | 220,190 | +321.0% | 0.06% | +276.5% |
| Q1 2023 | $5,708,568 | -68.6% | 52,305 | -67.3% | 0.02% | -70.2% |
| Q4 2022 | $18,203,562 | +148.2% | 159,961 | +35.0% | 0.06% | +147.8% |
| Q3 2022 | $7,335,000 | +51.2% | 118,513 | +94.8% | 0.02% | +53.3% |
| Q2 2022 | $4,852,000 | -73.2% | 60,835 | -64.6% | 0.02% | -66.7% |
| Q1 2022 | $18,103,000 | +93.5% | 172,062 | +98.1% | 0.04% | +87.5% |
| Q4 2021 | $9,357,000 | +542.2% | 86,835 | +552.9% | 0.02% | +500.0% |
| Q3 2021 | $1,457,000 | -66.5% | 13,300 | -71.4% | 0.00% | -66.7% |
| Q2 2021 | $4,354,000 | -5.6% | 46,500 | -7.2% | 0.01% | -20.0% |
| Q1 2021 | $4,611,000 | -11.3% | 50,100 | -29.5% | 0.02% | -6.2% |
| Q4 2020 | $5,201,000 | – | 71,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |